You are here

Other

U.S. data dashboard helps gauge effectiveness of state and local policies to mitigate COVID-19 impact.

Study gauges effectiveness of COVID-19 burden mitigation policies

In a new study published in JAMA Network Open, researchers have created a dataset and data visualization dashboard to evaluate the effectiveness of state and territory-level policies enacted to reduce the severity of COVID-19's impact on older people served by home health care agencies and nursing homes.

The authors found many policies within states and territories did not correspond with reductions in community or nursing home-level COVID-19 burden (i.e. number of cases and mortality counts). This suggests that policy effectiveness may depend on implementation and compliance. The study also found that policies focused less on home health care agencies compared with nursing homes, despite both settings serving vulnerable older populations.

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Vaccinations of teenagers cut COVID-19 cases by 37% in California--study

JAMA Network Open has published a new study showing that, from April 1, 2020, to February 27, 2023, in California, an estimated 146,210 COVID-19 cases were averted by vaccination in teens aged 12 to 15 years, representing a 37% reduction.

..

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

COP28: 124 Countries Commit to Milestone ‘Declaration on Climate and Health’

In what is being described as a historic and pivotal moment by top COP28 and World Health Organization (WHO) officials, 124 countries have endorsed the Declaration of Climate and Health. Dr Sultan Ahmed Al Jaber, President of COP28 in Dubai, made the announcement.

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Pfizer’s RSV vaccine shows potential to protect high-risk adults ages 18-59

Pfizer’s RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use

A vaccine from Pfizer showed the potential to protect adults ages 18 to 59 who are at increased risk of getting severely sick from respiratory syncytial virus in a late stage clinical trial, the company said Tuesday.

...

 

 

 

 

 

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Other
howdy folks
Page loaded in 0.554 seconds.